Here, we report the complete genome sequence of a SARS CoV 2 strain (NYI01 21) obtained from a patient with symptoms of COVID 19, who had a recent travel history to the United Kingdom. The sample was
This pathway describes the antagonistic effects of the SARS-CoV-2 B.1.1.7 (Alpha) variant on innate immune activation. The pathway is based on Figure 5 from [https://www.biorxiv.org/content/10.1101/20